Literature DB >> 23153674

Accumulation of tissue macrophages and depletion of resident macrophages in the diabetic thymus in response to hyperglycemia-induced thymocyte apoptosis.

Lucian Barbu-Tudoran1, Oana I Gavriliuc, Virgil Paunescu, Felix A Mic.   

Abstract

AIMS: We investigated the dynamics and morphology of thymus macrophages in response to thymus involution caused by hyperglycemia. Thymus is an organ affected early and dramatically after the onset of diabetes, losing most of the thymocyte populations but diabetes's impact on the components of the thymus stroma is largely unknown.
METHODS: Rats were injected with streptozotocin and thymus weight, body weight, and glycemia were measured at various time points. The dynamics and morphology of macrophages in the diabetic thymus were investigated by histology, immunohistochemistry, qPCR, electron microscopy and flow cytometry.
RESULTS: In hyperglycemic animals the involuting thymus is gradually infiltrated by tissue macrophages (ED1-positive) and depleted of resident macrophages (ED2-positive). While ED1 positive macrophages are scattered in both cortex and medulla the ED2 positive ones are limited to the cortex and cortico-medullary junction. CD4+CD11b+macrophages also accumulate. The TUNEL reaction that detects the degradation of the DNA from apoptotic thymocytes in the macrophages is enhanced. The thymic macrophages enlarge and accumulate lipid vacuoles and apoptotic bodies. qPCR measurements of the expression of macrophage markers showed a persistent increase in the diabetic thymus after the injection of streptozotocin.
CONCLUSIONS: Thymus involutes rapidly and persistently after the onset of hyperglycemia because of the elevated apoptosis in the thymocytes. Tissue macrophages accumulate in the thymus and the resident macrophages decrease. This results in an overall increase in macrophage activity in the diabetic thymus in response to the elevated apoptosis of thymocytes produced by hyperglycemia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153674     DOI: 10.1016/j.jdiacomp.2012.10.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  3 in total

1.  Genistein modulation of streptozotocin diabetes in male B6C3F1 mice can be induced by diet.

Authors:  Tai L Guo; Yunbiao Wang; Tao Xiong; Xiao Ling; Jianfeng Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-30       Impact factor: 4.219

Review 2.  Impact of Obesity and Metabolic Syndrome on Immunity.

Authors:  Catherine J Andersen; Kelsey E Murphy; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

3.  TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice.

Authors:  Daniel E Lefever; Joella Xu; Yingjia Chen; Guannan Huang; Nagy Tamas; Tai L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-21       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.